Expect surge in COVID-19 cases as test results from over 30 labs are delayed – DOH
Marje Pelayo • September 9, 2020 • 289
MANILA, Philippines – The Department of Health (DOH) sees a surge in the number of cases of coronavirus disease (COVID-19) in the coming days as over 30 laboratories in the country are still yet to submit their respective cases bulletin to the agency.
The DOH said 34 out of the 115 licensed testing laboratories have delayed results in their COVID-19 tests.
“This means there are confirmed cases per day that have not been reported yet officially and will come out this week,” said Health Undersecretary Maria Rosario Vergeire.
“We may have an irregularly high number of cases in the coming days as cases from these laboratories get reported. We will ensure to highlight which of these cases are late reports,” she added.
The DOH points at incomplete information such as patients’ address and contact number as the cause of the delays in submitting their case bulletins.
Such information is vital to the contract tracing efforts of the government.
On September 1, the DOH required the testing laboratories to encode all information of their patients because the agency’s COVID-19 Data Repository System does not accept incomplete information.
“The main factor was the change in or the additional two variables–the complete address and the phone numbers that were stated to be mandatory,” Vergeire said.
“Hindi makakapasok or makaka-upload sa system noong kanilang submission if hindi kumpleto ang kanilang fields doon sa kanilang CIFs na isa-submit sa atin [They will not be able to enter or upload their submission into our system if the fields in the CIFs are incomplete],” she stressed.
Nonetheless, the official confirmed that the results have been gradually coming in from the concerned laboratories since Tuesday (September 8).
Once the results from these laboratories are submitted, expect an increase in the number of COVID-19 cases in the DOH’s overall tally.
Should these laboratories still fail to submit their reports next week, Vergeire said the DOH will push to sanction them.
34 Labs failed to submit their data to the COVID-19 Data Repository System
1. AL Molecular Diagnostic Laboratory
2. Amosup Seamen’s Hospital
3. Bohol Containerized PCR Laboratory
4. Butuan Medical Center
5. Cagayan Valley CHD TB Reference Laboratory
6. Calamba Medical Center
7. Corazon Locsin Montelibano Memorial Regional Hospital
8. Dagupan Doctors Villaflor Memorial Hospital
9. Daniel O. Mercado Medical Center
10. Detoxicare Molecular Diagnostics Laboratory
11. Dr. Arturo P. Pingoy Medical Center
12. Fe Del Mundo Medical Center
13. Green City Medical Center
14. Hi-Precision Diagnostics QC
15. Ilocos Training Regional Medical Center (GX)
16. Marikina Molecular Diagnostic Laboratory
17. Marilao Medical and Diagnostic Clinic
18. NKTI – GX
19. Philippine Airport Diagnostic Laboratory
20. Philippine Heart Center
21. Philippine Red Cross
22. Philippine Red Cross – Clark Mol Lab (PAMPANGA)
23. Philippine Red Cross – Logistics and Training- SUBIC, ZAMBALES
24. Philippine Red Cross – Molecular Biology Laboratory
The Philippines records a total of 1,509 new cases of coronavirus disease (COVID-19) with 362,243 total cases, the Department of Health (DOH) reported on Wednesday (October 21).
The DOH also recorded 60 deaths and 911 recoveries. The day’s recorded recoveries brought the total number to 311,506.
Based on DOH COVID-19 Case Bulletin no. 221, 90% of the total daily cases occurred within the recent 14 days, while the top regions in the recent two weeks are in the National Capital Region (NCR) with 320 cases, and Region 4A with 297 cases.
The DOH also added that 41 duplicates were removed from the total case count. Thirty-one recovered cases and three deaths have also been removed from the list.
The University of the Philippines Octa Research Team said there are still areas with high COVID-19 cases since October 11, based on their research. These areas include several areas in the National Capital Region (NCR), Pasig, Makati, Pasay, Mandaluyong, and Marikina.
Meanwhile, DOH Spokesperson Usec. Maria Rosario Vergeire said 60-70% of the country’s population should be vaccinated against COVID-19 for herd immunity.
“It doesn’t stop there because we would need 60-70% of the population immunized so we can have herd immunity. So when we talk about P12.5 billion that is just covering our population,” she said. AAC (with reports from Aiko Miguel)
The Department of Health (DOH) and the World Health Organization (WHO) is encouraging the public to enroll in the free online course about mental health.
The QualityRights Mental Health e-training course was developed by WHO and translated in Filipino in partnership with the DOH. It aims to improve access to quality mental health and social services.
Participants of the online course, according to the Health Department, will be able to improve their own mental health as well as support their friends and love ones who are experiencing mental health problems.
Health Secretary Francisco T. Duque III hopes the free online course will be able to help in addressing the mental health conditions and cognitive disabilities in the country.
“Mental health is a major public health concern that needs to be openly discussed and addressed. With the e-learning modules translated in Filipino, we hope to educate more people and facilitate more discussions that will ultimately help us understand and address the need of Filipinos with mental health conditions, and other intellectual and cognitive disabilities,” he said. AAC
MANILA, Philippines – The clinical trials on anti-flu drug Avigan in the country may finally begin next week, the Department of Health (DOH) said.
Health Undersecretary Maria Rosario Vergeire said the process for the clinical trial is currently being finalized, adding that the proponent of the research has been given go signal to recruit study participants.
Vergeire said a minor issue on the insurance documents just needed to be fixed before they could begin the trial.
“Merong minor comment ang legal service namin for this insurance document. Iyon na lang but we already gave the go signal to the proponents,” she said.
“Kapag nakapag-recruit na tayo, hopefuly by next week talagang officially starting na tayo,” she added.
The clinical trial, which aims to look into the possible benefits of the Japan-made drug to coronavirus disease patients, will last for nine months. Four hospitals will participate in the trial.
It was supposed to start in August but was delayed due to some issues in legal arrangements.
Avigan tablets were delivered in early August by the Japanese government for the use of 100 patients. – RRD (with details from Correspondent Aiko Miguel)
UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.